MedTrace Logo

Autism Biomarker Consortium for Clinical Trials

NCT02996669 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2020-03-05

No results posted yet for this study

Summary

This is a multicenter longitudinal study that aims to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome. The main study will include 275 individuals: 200 ASD subjects between 6-11 years old, and 75 TD subjects roughly matched by age and sex to the ASD group.

Conditions

Sponsors & Collaborators

Principal Investigators

  • James McPartland, PhD · Yale University Child Study Center

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-05-13
Completion
2019-05-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02996669 on ClinicalTrials.gov